These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 20645022)
1. Pituitary adenylate cyclase-activating polypeptide is protective against oxidative stress in human retinal pigment epithelial cells. Mester L; Kovacs K; Racz B; Solti I; Atlasz T; Szabadfi K; Tamas A; Reglodi D J Mol Neurosci; 2011 Jan; 43(1):35-43. PubMed ID: 20645022 [TBL] [Abstract][Full Text] [Related]
2. Effects of PACAP on intracellular signaling pathways in human retinal pigment epithelial cells exposed to oxidative stress. Fabian E; Reglodi D; Mester L; Szabo A; Szabadfi K; Tamas A; Toth G; Kovacs K J Mol Neurosci; 2012 Nov; 48(3):493-500. PubMed ID: 22644900 [TBL] [Abstract][Full Text] [Related]
3. Pituitary adenylate cyclase activating polypeptide acts against neovascularization in retinal pigment epithelial cells. Fabian E; Reglodi D; Horvath G; Opper B; Toth G; Fazakas C; Vegh AG; Wilhelm I; Krizbai IA Ann N Y Acad Sci; 2019 Nov; 1455(1):160-172. PubMed ID: 31317557 [TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathways. Rácz B; Gallyas F; Kiss P; Tóth G; Hegyi O; Gasz B; Borsiczky B; Ferencz A; Roth E; Tamás A; Lengvári I; Lubics A; Reglodi D Regul Pept; 2006 Nov; 137(1-2):20-6. PubMed ID: 16945433 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism. Maugeri G; D'Amico AG; Bucolo C; D'Agata V Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of pituitary adenylate cyclase activating polypeptide in endothelial cells against oxidative stress-induced apoptosis. Rácz B; Gasz B; Borsiczky B; Gallyas F; Tamás A; Józsa R; Lubics A; Kiss P; Roth E; Ferencz A; Tóth G; Hegyi O; Wittmann I; Lengvári I; Somogyvári-Vigh A; Reglodi D Gen Comp Endocrinol; 2007; 153(1-3):115-23. PubMed ID: 17270184 [TBL] [Abstract][Full Text] [Related]
10. PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: implication for Parkinson's disease. Brown D; Tamas A; Reglödi D; Tizabi Y J Mol Neurosci; 2013 Jul; 50(3):600-7. PubMed ID: 23625270 [TBL] [Abstract][Full Text] [Related]
11. Protective Effects of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Against Oxidative Stress in Zebrafish Hair Cells. Kasica N; Podlasz P; Sundvik M; Tamas A; Reglodi D; Kaleczyc J Neurotox Res; 2016 Nov; 30(4):633-647. PubMed ID: 27557978 [TBL] [Abstract][Full Text] [Related]
12. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway. Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825 [TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress. Yang S; Yang J; Yang Z; Chen P; Fraser A; Zhang W; Pang H; Gao X; Wilson B; Hong JS; Block ML J Pharmacol Exp Ther; 2006 Nov; 319(2):595-603. PubMed ID: 16891616 [TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase activating polypeptide in the retina: focus on the retinoprotective effects. Atlasz T; Szabadfi K; Kiss P; Racz B; Gallyas F; Tamas A; Gaal V; Marton Z; Gabriel R; Reglodi D Ann N Y Acad Sci; 2010 Jul; 1200():128-39. PubMed ID: 20633141 [TBL] [Abstract][Full Text] [Related]
16. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes. Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551 [TBL] [Abstract][Full Text] [Related]
17. PACAP ameliorates oxidative stress in the chicken inner ear: an in vitro study. Racz B; Horvath G; Reglodi D; Gasz B; Kiss P; Gallyas F; Sumegi B; Toth G; Nemeth A; Lubics A; Tamas A Regul Pept; 2010 Feb; 160(1-3):91-8. PubMed ID: 19969027 [TBL] [Abstract][Full Text] [Related]
18. Effects of PACAP on oxidative stress-induced cell death in rat kidney and human hepatocyte cells. Horvath G; Brubel R; Kovacs K; Reglodi D; Opper B; Ferencz A; Szakaly P; Laszlo E; Hau L; Kiss P; Tamas A; Racz B J Mol Neurosci; 2011 Jan; 43(1):67-75. PubMed ID: 20676802 [TBL] [Abstract][Full Text] [Related]
19. The Neuropeptide Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) is Protective in Inflammation and Oxidative Stress-Induced Damage in the Kidney. Horvath G; Opper B; Reglodi D Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591326 [TBL] [Abstract][Full Text] [Related]